Experimental capabilities

HIGH-CONTENT IMAGING

Cell cycle and proliferation

Where does cell-cycle progression change?

Combining DNA content with DNA synthesis and mitotic markers reveals more than a change in cell number. It separates cell-cycle populations and helps characterise the response to an anti-proliferative treatment.

EXPERIMENTAL DATA

Cell-cycle scatter plots and pie charts for MCF7 cells at control and 0.03, 0.3 and 3 micromolar inhibitor, showing DNA content, EdU incorporation and changing cell-cycle fractions.Resolve cell-cycle distributions across concentrations.
Inventro experimental data from MCF7 cells: untreated control and 72 hours after exposure to a cell-cycle inhibitor. Scatter plots show DNA content and newly synthesised DNA; the phase fractions also incorporate phospho-histone H3 and dead-cell staining.

The method

  1. Label DNA synthesis

    Allow EdU incorporation during a defined labelling period to identify cells synthesising DNA. Detect the incorporated label at the assay endpoint.

  2. Measure complementary markers

    Measure DNA content with a nuclear dye and use phospho-histone H3 to identify mitotic cells. A dead-cell stain can provide additional context.

  3. Resolve populations

    Use single-cell measurements to estimate G1, S, G2 and M fractions and compare their distributions across treatment conditions.

Reading the results

Single-cell scatter plots, cell-cycle phase fractions and mitotic index. DNA content alone resolves G1, S and G2/M; EdU and a mitotic marker add information on DNA synthesis and mitosis.

Interpretation

A phase distribution is an endpoint snapshot, not a direct measurement of cell-cycle speed. Treatment duration, labelling window and cell loss influence the observed fractions and should be considered together.

Study design

The cell model, exposure time, EdU labelling period and marker panel are matched to the research question. The illustrated 72-hour MCF7 experiment is one study configuration.

LET'S TALK SCIENCE

Plan an experimental study.

Tell us about your compound, model and research question.

contact@inventro.coBack to experimental capabilities